Month: December 2023
-
2023: The year in review
- 22 Dec 2023
In our last edition for 2023, we looked at the issues and events that shaped the year. MedNews returns on 15 January 2024.
Read more -
Gilead gets second CAR T deal
- 20 Dec 2023
More than two years after its initial recommendation, Australians are finally close to funded access for the country’s third cell therapy.
Read more -
Is the Covid antiviral party over?
- 20 Dec 2023
MSD and Pfizer will have to take substantial price cuts if they want their Covid antiviral pills to continue to be listed on the PBS.
Read more -
HTA Review goes into overdrive
- 20 Dec 2023
The committee met thrice in the past week as it wades through a huge workload, an extended deadline only delaying the deluge.
Read more -
PBAC generosity hides Scrooginess
- 18 Dec 2023
While generous in handing out recommendations in November, the PBAC has ensured most big-ticket items stayed under its tree.
Read more -
Novo given (another) hand from PBAC
- 18 Dec 2023
While the PBAC has twice rejected its obesity drug Wegovy for PBS listing, the committee now wants to facilitate a funding solution.
Read more -
New year jobs snapped up
- 18 Dec 2023
A number of industry people have set themselves up for success by taking up exciting new roles before 2024 has even begun.
Read more -
Gallaher to lead new CGT centre
- 18 Dec 2023
Entrepreneur Michelle Gallaher named inaugural CEO of Cerulea, a new clinical trial centre investigating gene therapies for eye disorders.
Read more








